Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 13;13(1):712.
doi: 10.1038/s41598-022-25908-6.

Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic

Affiliations

Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic

Ana Rubia Guedes et al. Sci Rep. .

Abstract

In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital's Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Zuiani A, Wesemann DR. Antibody dynamics and durability in coronavirus disease-19. Clin. Lab. Med. 2022;42:85–96. doi: 10.1016/j.cll.2021.10.004. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Reinfections and COVID-19. Available at: https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html. Accessed 5 September 2022.
    1. Pilz S, Theiler-Schwetz V, Trummer C, Krause R, Ioannidis JPA. SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity. Environ. Res. 2022;8(209):112911. doi: 10.1016/j.envres.2022.112911. - DOI - PMC - PubMed
    1. Akinbami LJ, Biggerstaff BJ, Chan PA, McGibbon E, Pathela P, Petersen LR. Reinfection with severe acute respiratory syndrome coronavirus 2 among previously infected healthcare personnel and first responders. Clin. Infect. Dis. 2022;75(1):e201–e207. doi: 10.1093/cid/ciab952. - DOI - PMC - PubMed
    1. Plumb ID, Feldstein LR, Barkley E, et al. Effectiveness of COVID-19 mRNA vaccination in preventing COVID-19-associated hospitalization among adults with previous SARS-CoV-2 infection—United States, June 2021–February 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71(15):549–555. doi: 10.15585/mmwr.mm7115e2. - DOI - PMC - PubMed

Publication types

Supplementary concepts

LinkOut - more resources